-
Notifications
You must be signed in to change notification settings - Fork 1
Expand file tree
/
Copy pathindex.html
More file actions
178 lines (161 loc) · 10.5 KB
/
index.html
File metadata and controls
178 lines (161 loc) · 10.5 KB
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
<!doctype html>
<html lang="en">
<head>
<meta charset="utf-8" />
<title>DexTech Medical</title>
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<!-- 1140px Grid styles and HTML5-Shiv for IE -->
<!--[if lte IE 9]>
<link rel="stylesheet" href="css/ie.css" type="text/css" media="screen" />
<script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<!-- The 1140px Grid - http://cssgrid.net/ -->
<link rel="stylesheet" href="css/1140.css" type="text/css" media="screen" />
<link rel="stylesheet" href="css/styles.css" type="text/css" media="screen" />
<!--css3-mediaqueries-js - http://code.google.com/p/css3-mediaqueries-js/ - Enables media queries in some unsupported browsers-->
<script type="text/javascript" src="js/css3-mediaqueries.js"></script>
</head>
<body>
<header class="container">
<div class="row">
<div class="twelvecol last">
<img id="abstract" src="img/header_abstracts.png" alt="" />
<h1>
<img src="img/logo.png" alt="DexTech"/>
</h1>
<span>Know-how in Translational Research</span>
</div>
</div>
</header>
<div class="container" id="main">
<div class="row">
<div class="sixcol">
<h2 style="margin-top: 43px;">Kommuniké från extra bolagsstämma</h2>
<p>
<a href="kommunike_dextech_medical_140423.doc" target="_blank">- Ladda ner (.doc)</a>
</p>
<hr />
<h2>Kallelse till extra bolagsstämma i Dextech Medical AB (publ)</h2>
<p>Aktieägarna i Dextech Medical AB (publ), 556664-6203, kallas härmed till extra bolagsstämma tisdagen den 22 april 2014 kl. 15.00 på Birger Jarlsgatan 41A, 6 tr, i Stockholm.</p>
<p>
<a href="PM_Kallelse_Dextech_Medical_140404.doc" target="_blank">- Ladda ner kallelse (.doc)</a><br />
<a href="DexTech_Medical_arsredovisning_2012-13.pdf" target="_blank">- Årsredovisning 2012-07-01 - 2013-06-30 (.pdf)</a><br />
<a href="Fullstandiga_beslutsunderlag_DexTech_Medical.pdf" target="_blank">- Fullständigt beslutsunderlag inför extra bolagsstämma (.pdf)</a><br />
<a href="Fullmaktsformular_extra_bolagsstamma_DexTech_Medical_140422.pdf" target="_blank">- Fullmaktsformulär (.pdf)</a><br />
<a href="DexTech_styrelsens_redogorelse.pdf" target="_blank">- Styrelsens redogörelse</a>
</p>
<hr />
<p> </p>
<h2>About us</h2>
<p>DexTech develops drug candidates for urologic oncology, especially prostate cancer, based on glycosylation engineering.</p>
<p>Close connection between R&D and clinical oncology ensures development of tools for real clinical problems.</p>
<p>DexTech was established in 2004 by:</p>
<ul>
<li><span class="highlight">Anders R Holmberg</span>, a chemical engineer with a PhD in experimental oncology. He is an expert in glycosylation chemistry.</li>
<li><span class="highlight">Sten Nilsson (MD, PhD)</span>, a specialist in clinical oncology (urologic oncology, especially prostate cancer).</li>
</ul>
<p>Anders R Holmberg is managing director and Sten Nilsson is our clinical expert and member of the board.</p>
</div>
<div class="sixcol last" id="illustration">
<img src="img/illustration.png" alt=""/>
</div>
</div>
<div class="row">
<div class="sixcol">
<h2>Contact</h2>
<h3>Visiting Address</h3>
<address>
Birger Jarlsgatan 41A, SE-111 45,
Stockholm, Sweden.
</address>
<h3>Postal Address</h3>
<address>Box 119, SE-75104 Uppsala, Sweden.</address>
<h3>Telephone & Email</h3>
<p>+46.8.613 1304 (Mr Kanekrans), <br>
<a href="mailto:arh@telia.com">arh@telia.com</a> (Anders R Holmberg).</p>
<h3>Investor Relations</h3>
<p>
Mr Peter Kanekrans: +46.8.613 1304, <a href="mailto:peter.kanekrans@dextechmedical.com">peter.kanekrans@dextechmedical.com</a>.
</p>
</div>
<div class="sixcol last">
<h2>Drug candidates</h2>
<p><span class="highlight">SomaDex</span>, for treatment of acromegaly, neuroendocrine tumors and palliative treatment of advanced prostate cancer, for licensing</p>
<p><span class="highlight">OsteoDex</span>, for treatment of bone metastasis in advanced prostate cancer (phase1-2a completed), preparations for phase 2 in progress</p>
<p><span class="highlight">CatDex</span>, anti-microbic agent in development</p>
<p>IPR is protected by a family of three world wide applied patents/applications including China and India.</p>
<h2>Technology</h2>
<p><span class="highlight">GuaDex</span> platform for glycosylation.</p>
</div>
</div>
<div class="row">
<div class="twelvecol last">
<h2>Partners and Network</h2>
</div>
<div class="threecol">
<h3>Europe</h3>
<ul>
<li>Helsinki University Hospital, Finland</li>
<li>European Institute of Oncology, Milan, Italy</li>
<li>Ångströmlab, Uppsala University, Sweden</li>
<li>Atlantic Bone Screen, Nantes, France</li>
<li>PharmaPlus Consultancy, The Netherlands</li>
<li>University Trás-os-Montes och Alto Douro, Vila Real, Portugal</li>
</ul>
</div>
<div class="threecol">
<h3>Middle East/Asia</h3>
<ul>
<li>King Feisal Research Center, Ryijad, Saudi Arabia</li>
<li>The Weizmann Institute of Science, Israel</li>
<li>Shandong University Hospital, Shandong, China</li>
<li>Beijing Univ., Beijing, China</li>
</ul>
</div>
<div class="threecol">
<h3>North America</h3>
<ul>
<li>Sloan Kettering Memorial Cancer Center, New York, USA</li>
<li>UANL, Monterrey, Mexico</li>
<li>UDEM/Mougerza Hospitals, Monterrey, Mexico</li>
<li>TechSphere Corp. Mexico City, Mexico</li>
</ul>
</div>
<div class="threecol last">
<h3>South-America</h3>
<ul>
<li>Ipiranga University Hospital, Sao Paolo, Brazil</li>
</ul>
</div>
</div>
<div class="row" id="related_publications">
<div class="twelvecol last">
<h2>Selection of Related Publications</h2>
<ol>
<li><a href="http://np.netpublicator.com/netpublication/n08729614">The hunt for new treatments</a>. Holmberg A. R. Prostate Cancer report in The Times newspaper, 02 December 2008</li>
<li><a href="http://np.netpublicator.com/netpublication/n32395664">Bones and prostate cancer</a>. Holmberg A. R. Prostate Cancer report in The Times newspaper, 28 October 2009</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/11877759">A novel somatostatin conjugate with high affinity to all five somatostatin receptor subtypes</a>. U. Wulbrand, M. Feldman, A. Pfestroff, H-C. Fehman, J. Du, J. Hiltunen, M. Marquez, S. Arnold R., Westlin J.E., Nilsson, and A. R. Holmberg. Cancer. 94; 4:1293-1297. Feb 15, 2002.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/15650261">Phase I trial on sms-D70 somatostatin analogue in advanced prostate and renal cell cancer</a>. Joensuu T.K., Nilsson S, Holmberg A.R., Marquez M, Tenhunen M, Saarto T and Jeonsuu H. Ann. N.Y. Acad Sci.1028:361-371, 2004.</li>
<li><a href="http://np.netpublicator.com/netpublication/n99233373">When prostate cancer becomes incurable</a>. Holmberg A.R. Prostate Cancer report in The Times newspaper, 26 October 2010</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/22199272">Treatment of bone metastasis in prostate cancer: efficacy of a novel polybisphosphonate</a>. Daubine F, LE Bot R, Márquez M, Nilsson S, Schröder T, Holmberg AR. Andticancer Research 31:4141-4146, 2011.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/17390019">Somatostatin effects on the proteome of the LNCaP cell-line</a>. Zhaoxu Liu, Sofia Bengtsson, Morten Krogh, Marcela Marquez, Sten Nilsson, Peter James, Ayodele Aliaya, and Anders R. Holmberg. Int. J. Oncology, 2007.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19578741">Polymer-conjugated guanidine is a potentially useful anti-tumor agent</a>. Meurling L, Márquez M, Nilsson S and Holmberg AR. Int J Oncol 35: 281-285, 2009.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/20664925">Development of a Novel Poly Bisphosphonate Conjugate for Treatment of Skeletal Metastasis and Osteoporosis</a>. Anders R. Holmberg, Ulf H. Lerner, Ayodele Alyia, Mai Al-Mohanna, Chaker Adra, Marcela Marquez, Lennart Meurling, and Sten Nilsson. Int J Oncology, 37, 563-567, 2010.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/21818805">Application of accelerator mass spectrometry to macromolecules: preclinical pharmacokinetic studies on a polybisphosphonate</a>. Mehran Salehpour, Karl Håkansson, Urban Höglund, Annika Grahn-Westin, Sten Nilsson, Marcela Márquez, Göran Possnert and Anders R. Holmberg. Rapid Commun. Mass Spectrom. 25, 2453–2458, 2011.</li>
</ol>
</div>
</div>
</div>
<footer class="container">
<div class="row">
<div class="twelvecol last">
<address>
Birger Jarlsgatan 41A, 111 45 Stockholm, Sweden.
</address>
<img id="footer_logo" src="img/footer_logo.png" alt="DexTech Medical AB" />
<img id="footer_abstract" src="img/footer_abstract.png" alt="DexTech Medical AB" />
</div>
</div>
</footer>
</body>
</html>